Immunome Inc. (IMNM) SEC Filings — 2024
33 SEC filings for Immunome Inc. (IMNM) in 2024.
Filings
- Immunome Inc. SC 13G Filing — SC 13G · Nov 14, 2024
- Immunome Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Immunome Inc. SC 13G Filing — SC 13G · Nov 14, 2024
- Immunome Inc. Files 8-K on Financials and Operations — 8-K · Nov 13, 2024
- Immunome Reports Q3 Loss, Details Equity Transactions — 10-Q · Nov 13, 2024
- Immunome Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Immunome Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Immunome Inc. SC 13G Filing — SC 13G · Nov 8, 2024
- Immunome Inc. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Immunome Inc. Reports Material Agreements & Asset Changes — 8-K · Oct 29, 2024
- Immunome Inc. SC 13G Filing — SC 13G · Oct 22, 2024
- Immunome to Combine with ROME Therapeutics — 8-K · Oct 8, 2024
- Barchas Amends Immunome Stake Filing — SC 13D/A · Aug 21, 2024
- Immunome Inc. Files 8-K on Operations and Financials — 8-K · Aug 12, 2024
- Immunome Inc. Q2 2024 Update: Cash Position and Financing Activities — 10-Q · Aug 12, 2024
- Immunome Inc. Reports on Security Holder Vote — 8-K · Jun 13, 2024
- Immunome Inc. Files 8-K on Operations and Financials — 8-K · May 14, 2024
- Immunome Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Immunome Appoints New CMO and Board Members — 8-K · Apr 30, 2024
- Immunome Inc. Announces 2024 Annual Meeting of Stockholders on June 12 — DEF 14A · Apr 26, 2024
- Immunome Inc. Appoints New Chairman, Adjusts Executive Compensation — 8-K · Apr 25, 2024
- Immunome Inc. Files 8-K on Operations and Financials — 8-K · Mar 28, 2024
- Immunome Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Immunome Inc. Files 8-K: Material Agreement, Asset Deal, Equity Sales — 8-K · Mar 26, 2024
- Immunome 8-K Filed: Event Details Not Included in Provided Text — 8-K · Feb 14, 2024
- Immunome Files 8-K on Financials and Other Events — 8-K · Feb 13, 2024
- Alpine Global Cuts Immunome Stake to 0.4% as of Dec 31, 2023 — SC 13G/A · Feb 12, 2024
- FMR LLC Discloses 9.14% Stake in Immunome Inc. — SC 13G · Feb 9, 2024
- Immunome Sells New Equity, Raises Capital — 8-K · Feb 6, 2024
- Immunome 8-K: Leadership/Compensation Changes Reported Jan 31, 2024 — 8-K · Feb 1, 2024
- Immunome 8-K Signals Major Corporate Event, Broad Shareholder Comms — 8-K · Jan 11, 2024
- Immunome Sells Equity Securities in Unregistered Offering — 8-K · Jan 8, 2024
- Immunome 8-K Signals Executive/Comp Changes on Jan 2, 2024 — 8-K · Jan 2, 2024